Digital Technology Product Owner, Medical Affairs
argenx
Summary
This role will own the technology vision and value delivery for our Medical Affairs and Evidence Generation capability within Digital Technology (DT) Commercial. It is accountable for translating the goals of our Medical Affairs and Evidence Generation teams into a clear product vision and a prioritized backlog for platforms that support scientific exchange. By acting as the primary liaison between medical experts and technical teams, ensuring all solutions meet key compliance standards, and enabling the use of technology to generate insights, this position is directly responsible for ensuring our digital ecosystem supports effective and compliant medical engagement.
Job description
Roles & Responsibilities
- Own the digital product vision and prioritize the backlog for key Medical Affairs and Evidence Generation platforms, including Medical CRM and scientific exchange tools.
- Act as the primary medical-to-tech liaison, translating complex scientific engagement and evidence generation needs into clear, actionable user stories.
- Ensure all digital solutions strictly adhere to non-promotional regulations and medical integrity standards, embedding compliance into the design process.
- Drive the development of tools and analytics to capture and analyze global medical insights, enabling data-driven strategic decision-making for Medical Affairs and Evidence Generation leadership.
- Act as the steward for the end-to-end user experience for Medical Affairs and Evidence Generation platforms, ensuring they are intuitive and effective for field medical teams and HCPs.
- Define and monitor Key Performance Indicators (KPIs) for success, continuously measuring the value and impact of the technology on scientific engagement objectives.
- Provide clear, day-to-day direction to various delivery teams on what to build next, ensuring alignment with Medical Affairs priorities.
- Serve as the primary point of contact for delivery teams, providing constant feedback and clarification on medical requirements to empower effective execution.
Skills and Competencies
- Deep knowledge of product management principles, particularly in defining a product vision and strategy that aligns with Medical Affairs and Evidence Generation goals.
- Skilled in translating complex scientific or medical business needs into clear requirements and user stories for technical teams.
- Ability to own and prioritize a product backlog based on scientific value and strategic importance within a regulated pharmaceutical environment.
- Expert knowledge of the legal and regulatory compliance framework governing non-promotional activities and scientific exchange in the pharmaceutical industry.
- Knowledge of the digital technologies that support Medical Affairs and Evidence Generation, such as Medical CRM and platforms for insight gathering and scientific content dissemination.
- Ability to work collaboratively and effectively together within cross-functional teams and networks.
- Demonstrated communication skills, within a multi-cultural and multi-lingual global environment.
- Is agile and demonstrates adaptability, comfort with ambiguity, trust-building, and resilience.
- Drives toward outcomes.
- Ambitious, inquisitive naturally, a quick study, with demonstrated eagerness to continuously learn, self-improve and develop.
- This includes being comfortable giving and receiving feedback in a diverse environment.
- Passionate and prepared to lead and contribute to our culture, which is driven by our corporate values of co-creation, innovation, empowerment, excellence, and humility.
Education, Experience & Qualifications
- Bachelor’s or Master Degree preferred in Life Sciences, Pharmacy, Information Technology, Business Administration, or related fields.
- 5+ Years experience as a Product Owner, Product Manager, or Business Analyst with a focus on delivering solutions for Medical Affairs, Clinical, or R&D functions.
- 5+ Years experience in the pharmaceutical or life sciences industry, with a strong understanding of Medical Affairs and Evidence Generation business processes and compliance requirements.
- 5+ Years experience owning a product roadmap and using KPIs to measure and communicate the value of technology solutions to scientific or medical stakeholders.
- Up to 20% travel required
Requirements
- Bachelor’s or Master Degree preferred in Life Sciences, Pharmacy, Information Technology, Business Administration, or related fields.
- 5+ Years experience as a Product Owner, Product Manager, or Business Analyst with a focus on delivering solutions for Medical Affairs, Clinical, or R&D functions.
- 5+ Years experience in the pharmaceutical or life sciences industry, with a strong understanding of Medical Affairs and Evidence Generation business processes and compliance requirements.
- 5+ Years experience owning a product roadmap and using KPIs to measure and communicate the value of technology solutions to scientific or medical stakeholders.
- Up to 20% travel required
Benefits
- Retirement savings plans
- Health benefits
- Short-term incentive programs
- Long-term incentive programs
Company overview
argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Founded in 2008 and headquartered in Amsterdam, Netherlands with major operations in Boston, Massachusetts, argenx is a commercial-stage, fully-integrated biopharma company developing a deep pipeline of differentiated antibody-based therapies. The company's core innovation engine is its Immunology Innovation Program (IIP), which partners with leading academic researchers to translate immunology breakthroughs into novel medicines. argenx has developed and commercialized VYVGART, the first approved FcRn blocker available in more than 30 countries for conditions like generalized myasthenia gravis (gMG), chronic inflammatory demyelinating polyneuropathy (CIDP), and immune thrombocytopenia (ITP). The company leverages its proprietary SIMPLE ANTIBODY™ platform technology based on llama immune systems to access novel disease biology targets, combined with antibody engineering technologies like NHANCE™ and ABDEG™ to enhance therapeutic properties. With over 1,500 employees globally and listed on both Euronext Brussels and Nasdaq, argenx maintains a robust pipeline including empasiprubart (C2 inhibitor) in Phase 3 trials and several earlier-stage experimental medicines targeting various autoimmune conditions.